MSJ-100 Index
1,036.65
Signal breadth
4 Bullish 93 Neutral 3 Bearish Avg confidence 6.16 / 10
View full MSJ-100 ↗
PM
Philip Morris International Inc.
Consumer Staples · NYSE: PM · MSJ-100
$175.95
▼ $4.24  (▼2.35%) today
After-hours: $177.97  ▲ 1.15%
Headquarters
Stamford, CT
Employees
84,900
Founded
2008
CEO
Mr. Jacek Olczak
Incorporated
Virginia
Fiscal Year End
December
Analyst price target range Free
Avg target $194.86
$176 now
Bear $171 Avg $195 Bull $210
Price history Free
Volume
4.63M
Avg volume
4.95M
Open
$180.68
Day high / low
$182.00 / $175.84
Market cap
$274.2B
About this company
Free
Philip Morris International is a leading international consumer goods company focused on transitioning to a smoke-free future. Its core products include cigarettes and a growing portfolio of smoke-free alternatives like heated tobacco, nicotine pouches, and e-vapor products. The company is also expanding into wellness offerings outside the traditional tobacco and nicotine sector.
Business segments
10-K
Europe Region South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region East Asia, Australia, and PMI Global Travel Retail Americas Region
Recent News
Loading news...
Earnings call: Q1 2026 2026
Intel
Free
Apr 22, 2026Optimistic
● Full transcript on file
Jacek Olczak (Chief Executive Officer), Emmanuel Babeau (Chief Financial Officer), Adam Astley (Vice President, Investor Relations)
Key metrics
Q1 2026 EPS was $1.96, beating consensus estimates of $1.83 by $0.13.[2][4] Net revenues were about $10.1–$10.15 billion, up roughly 9% year over year and ahead of forecasts near $9.9–$9.95 billion.[2][4] Adjusted operating income rose around 10% to approximately $4.2 billion, net margin was reported around 11–12%, and the company maintained its di
Forward guidance
Management reaffirmed full‑year 2026 adjusted EPS guidance of $8.36–$8.51, reflecting 9–12% growth on an organic basis and assuming continued strength in smoke‑free products.[4][5] They guided Q2 2026 EPS to approximately $2.02–$2.07, with organic net revenue growth of 5–7%, driven by heated tobacco units (HTUs) and nicotine pouches.[2][4][5]
Notable Q&A
One analyst asked about the sustainability of IQOS volume growth in the face of regulatory changes in the EU and competitive dynamics in the U.S.; management responded that they see robust demand, expanding device penetration, and are adapting flavor portfolios and marketing within evolving regulati
Surprise items
EPS and revenue both came in meaningfully above consensus, with stronger‑than‑expected contributions from smoke‑free products, particularly IQOS and ZYN.[2][4] Management maintained relatively strong full‑year and Q2 guidance despite macro and regulatory headwinds, which was taken as a positive surp
Q4 2025 (Feb 08, 2026) · Optimistic
Fundamentals
Signal
52-week high / low
$193.05 / $142.11
Forward P/E
19.3×
Trailing 24.8×
Dividend
$5.88 / share
Yield 3.26%
Analysts covering
14
Avg target $194.86
Beta
0.41
vs. S&P 500
Short interest
1.2%
Float shorted
Buy
73%
Hold
27%
Sell
0%
Wall Street consensus — sourced weekly via public disclosures
Analyst coverage data sourced from public filings. Xavier analyst thesis summary available after weekly Perplexity scan completes.
Financial summary — Gemini analysis
Signal
Revenue
$40,648 million
7.3% YoY
Operating margin
36.6%
Net income
$11,348 million
Free cash flow
$10,664 million
Dividend / share
$5.88
Total debt
$48.8 billion
Cash: $4,872 million
CapEx guidance
$1.4 billion to $1.6 billion
Earnings quality: HIGH
Recurring revenue:41%
Cash conversion:1.1x
Non-recurring items: Restructuring charges of $241 million related to the end of combustible tobacco production in two German factories., Goodwill impairment charge of $41 million for a reporting unit within the Europe segment., Germany excise tax classification litigation charge of $176 million related to TEREA consumables., Loss on expected sale of consumer accessories and other businesses of $94 million.
Source: SEC 10-K filing analyzed by Gemini 2.5 Flash · 2026-02-06
Xavier sector view:
Consumer Staples
See journal
View Consumer Staples journal ↗
Xavier's signal
NEUTRAL
Signal
Confidence 6.2 / 10  ·  100% model agreement  ·  Scheduled Jul 12, 2026
PM trades at ~25.6x TTM P/E and ~22x forward P/E at $181.62, sitting 6% below its 52-week high with Q2 2026 earnings due July 22 — 7 trading days out. The stock has already rallied ~70% over two years and re-rated substantially on ZYN and IQOS growth; the fundamental story is strong but widely known and largely priced in. The near-term setup is a holding pattern: meaningful upside requires an earnings beat and guidance raise next week, while downside risk is capped by the defensive low-beta profile and dividend support.
Strongest bull case
Exceptional regulatory tailwinds: FDA recently issued MRTP orders for 20 ZYN variants (the first-ever for nicotine pouches) and renewed IQOS MRTP authorization in April 2026, removing overhang and validating the smoke-free growth narrative heading into a Q2 print where PM has beaten EPS estimates in each of the last four quarters.
Strongest bear case
Q2 2026 earnings on July 22 create binary risk: the stock surged 7% after Q1 but guidance for Q2 adjusted EPS of $2.02–$2.07 is well-telegraphed, and analysts have recently cut price targets from ~$183 to ~$180 while Jefferies downgraded, signaling diminishing upside at current valuation; a miss or weak ZYN volume data could quickly reverse the recent advance from the $142 low.
What the market may be missing
The $500M non-cash impairment charge on the Canadian affiliate (Rothmans, Benson & Hedges) embedded in 2026 reported EPS guidance is masking what would otherwise be a clean beat setup; if management guides toward resolving or monetizing the Canadian business, the gap between reported ($7.18–$7.33) and adjusted ($8.36–$8.51) EPS could compress, acting as a surprise re-rating catalyst the market is treating as a noise item.
Model breakdown
Signal
Atlas (Claude) — NEUTRAL
Meridian (GPT-4) — NEUTRAL
Grayline (Grok) — NEUTRAL
Vantage (Gemini) — NEUTRAL
msj100_PM_20260712T003715Z
Peer comparison
Signal
PM
current
$175.95 ▼2.4%
KR
NEUTRAL
$60.54
COST
NEUTRAL
$916.25
KO
NEUTRAL
$83.49
PEP
NEUTRAL
$137.38
Recent SEC filings
Signal
P2 AUTO
8-K — 2026-07-09
View filing on SEC EDGAR ↗
P2 COND
8-K — 2026-06-29
View filing on SEC EDGAR ↗
P2 AUTO
8-K/A — 2026-06-16
View filing on SEC EDGAR ↗
LOG
8-K — 2026-06-11
View filing on SEC EDGAR ↗
LOG
8-K — 2026-06-02
View filing on SEC EDGAR ↗
CEO scorecard — Jacek Olczak
Signal summary
Full detail Pro
JO
Jacek Olczak
Group CEO PMI · Philip Morris International Inc.
CEO since 2021
Total compensation
$29,072,171 ▲ 43.6% YoY
Prior year: $20,237,916
Pay vs performance
Aligned
Board assessment
Say-on-pay approval
95%
Shareholder vote
Board independence
8/10 (80%)
Base salary$1,926,318
Bonus / incentive$5,217,391
Stock awards$18,033,564
Executive appearances
Intel
Free
Investor DayMay 12, 2026
2026 Annual Meeting of Shareholders Source ↗
Mr. Jacek Olczak (CEO) · Virtual
Jacek Olczak presented an overview of PMI's remarkable 2025 performance with net revenues surpassing $40 billion, including nearly $17 billion from smoke-free products, and a robust start to 2026. Smoke-free products accounted for 43% of Q1 2026 net
“"remarkable performance in 2025, and robust start to 2026"”
ConferenceApr 17, 2026
Semafor World Economy Source ↗
Mr. Jacek Olczak (CEO) · Washington, DC
Jacek Olczak discussed the surprising impacts of the AI revolution on employment and competition. He predicted that job candidates will soon prioritize AI usage in workplaces. He advocated for faster AI adoption globally, following China's lead in co
“"Soon, you’ll have the first employees applying for the job and they’ll ask the questions, ‘Can I, and to what extent I can use AI in your office?’ And if your answer is, ‘Sorry, we’re still thinking ”
InterviewApr 15, 2026
Semafor World Economy Editorial Interview Source ↗
Mr. Jacek Olczak (CEO) · Semafor
Olczak urged countries to emulate China's rapid AI adoption through consumer promotions to integrate AI into daily life. He highlighted opportunities for AI in workplaces despite challenges in implementation. The discussion positioned PMI as forward-
“"I wish that in other parts of the world, not just in China, that we also focus on the thing, let people adopt it faster."”
CEO letter to shareholders
Signal
Full letter Pro
Jacek Olczak 2025 Annual Report OPTIMISTIC

Dear Shareholder,

2025 was another remarkable year for PMI, with a fifth consecutive

year of volume growth, net revenues surpassing $40 billion, including

close to $17 billion from our smoke-free business, and further

operating margin expansion. Our performance continues to be

fueled by the international business, which generated most of our

organic net revenue growth, led by smoke-free products.

Our business yet again delivered best-in-class top- and bottom-line

growth and outperformed the industry. This demonstrates not only

the strength of our global organization but also the sustainability

of our evolved business model as we continued to advance our

smoke‑free leadership.

Our achievements this year are a testament to the dedication of

PMI’s around 84,900 employees worldwide, who once again brought

their passion, resilience, and talent to everything they do. We extend

our sincere thanks for their unwavering commitment and hard work.

2025 vs. 2024 Results

Estimated international industry4 volume for cigarettes and heated

tobacco units (HTUs) was broadly stable, with a 1.1% decrease for

cigarettes, largely offset by 10.2% growth of HTUs.

In the fifth consecutive year of total shipment volume growth

(up by 1.4%), our smoke-free shipments increased by 12.8%. This

impressive increase reflects strong HTU growth, accelerating

traction in nicotine pouches, and a doubling of e‑vapor volumes.

Cigarette shipment volumes declined by 1.5%.

Our total cigarette and HTU volume share reached 29.2% of the

international industry, up by 0.2 percentage points fueled by HTU

performance (up by 0.5 percentage points).

Net revenues increased by 7.3% to $40.6 billion. On an organic basis

net revenues increased by 6.5%, mainly driven by favorable pricing

as well as smoke-free volume growth and a corresponding positive

product mix impact.

Operating income increased by 11.1% to $14.9 billion (10.6% on an

organic basis), supported by the same drivers as net revenues, partly

offset by higher marketing, administration and research costs.

Diluted EPS increased to $7.26 compared to $4.52 in 2024. Adjusted

diluted EPS of $7.54 increased by 14.2%, excluding currency.

In 2025 PMI delivered operating cash flow of $12.2 billion, matching

the record performance in 2024. On a currency-neutral basis,

operating cash flow decreased by 3.8% primarily due to higher

working capital requirements.

In September, the Board of Directors approved an 8.9% increase

in the quarterly dividend to an annualized rate of $5.88 per share.

This represented the highest increase since 2013 and the eighteenth

consecutive year of dividend growth since becoming a public

company in 2008.

Delivering a Smoke-Free Future

In 2025, our smoke-free business accounted for 41.5% of total

net revenues. In the fourth quarter we achieved a key milestone:

over 50% of net revenues generated by the smoke-free business

in three of our four regions. On a full-year basis, we reached the

same milestone in 27 markets and 8 markets exceeded 75%. As of

year-end, our smoke-free products were available in 106 markets,

with over 43 million estimated adult consumers.5 Our smoke-free

business continued its upward trajectory in profitability. IQOS was

again the primary driver of this performance, combining global top-

line momentum with increasing scale and cost efficiencies, coupled

with VEEV’s improving profitability and ZYN’s best-in-class gross

margins.

IQOS continued to strengthen its position as the second-largest

nicotine ‘brand’ in markets where present, with the number one

volume share position in 13 markets, and drove the growth of the

global heat-not-burn category, where PMI holds approximately 76%

volume share. This was supported by brand engagement initiatives

and continuous innovation across devices and consumables,

including the expansion of ILUMA i, which is now6 available in 55

out of 79 IQOS markets. In December 2025 an important landmark

was reached in Japan, where over 50% of the total industry was

smoke-free on an offtake volume basis, driven by the heat-not-

burn category where IQOS holds the number one position. To

complement IQOS, PMI continues to invest in a range of innovative

and high-quality heat-not-burn alternatives. This includes BONDS,

our peripheral heating system.

We continue to expand in the attractive oral smoke-free category,

with ZYN modern oral pouches now6 available in 56 markets across

the globe. Total oral smoke-free shipment volume7 in pouches or

pouch equivalents increased versus the prior year by 18.5%, driven by

nicotine pouches, which grew by 36%. The nicotine pouch category

remains nascent in most geographies.

In the vaping category, VEEV is the fastest-growing brand of any

major player in international closed pods and holds the number one

position in eight markets. The pod segment is growing rapidly as

disposables decline, and VEEV is gaining significant volume share in a

fragmented landscape, sourcing primarily from consumers of other

vaping products and adult smokers. VEEV’s profitability improved

further while shipment volumes more than doubled.

PMI’s complementary brand portfolio with high-quality products in

all three smoke-free categories allows us to better serve consumers

and enhance our financial performance. Our multicategory strategy

is a critical catalyst for smoke-free product adoption by adult

consumers and an important driver of our long-term growth. It has

already been deployed in 52 markets, including over 25 markets with

the IQOS, ZYN and VEEV brands now commercialized together.

Smoke-Free Product Regulation

2025 was a critical year for advancing regulatory frameworks for

smoke‑free products around the world. While progress remains

uneven across geographies, we saw growing recognition of harm

reduction principles and more consistent differentiation between

categories.

The number of markets with a dedicated excise tax category for

heat-not-burn, e-vapor and modern oral is steadily growing. The

introduction of product definitions for all smoke-free categories

with an appropriate tax differential versus cigarettes is crucial to

accelerate the switching of smokers to better alternatives. Some

setbacks also occurred, including Japan’s adoption of an excise

equalization plan for heated tobacco and cigarettes in 2026, albeit

with a more consistent tax structure and visibility on future excise

increases on both cigarettes and heated tobacco.

Market access for smoke-free products continues to expand. The

number of markets that have either proceeded with a dedicated

or improved regulatory framework or lifted a regulatory ban for at

least one smoke-free product category reached 85. This includes

the long-awaited authorization of IQOS in Taiwan. We continue

to advocate for effective harm reduction measures, especially in

markets such as Turkey, India, Brazil and Vietnam, where smoke-

free products are banned, resulting in the perpetuation of cigarette

consumption.

Combustible Tobacco Product Portfolio

Our combustible portfolio continues to play a vital role in our quest

to transition adult smokers to better alternatives. It provides the

financial stability, infrastructure, and consumer relationships that

support long‑term investment in our smoke‑free journey.

Our combustibles business remained resilient and, with disciplined

management, delivered another year of strong performance.

Notwithstanding expected lower volumes, net revenues grew by

2.5%, driven by strong pricing, partly offset by geographic mix.

Marlboro remains the world’s best‑selling cigarette brand and

reached an all-time high of 11.0% volume share of the international

cigarette market in the fourth quarter of 2025, despite over-indexing

to IQOS cannibalization.

Organization

We continue to evolve and develop our organization, including the

introduction of a new organizational model effective January 1,

2026. With our smoke-free business now operating at scale across

our regions, including substantial growth from our U.S. business,

PMI has implemented an evolved organizational model with

two primary business units: International and U.S. The updated

organizational structure is designed to enhance our agility and to

support our journey to become a smoke-free company. As a result,

PMI realigned its reportable segments accordingly, with the four

geographic segments replaced with three new reportable segments:

International Smoke-Free, International Combustibles, and U.S. Our

reporting will reflect these changes as of the first quarter of 2026.

Our digital transformation is advancing rapidly, supported by

our global digital consumer platforms and the scaling of proven

initiatives enabled by artificial intelligence. To strengthen the

foundations for the future, we invest in our people by advancing

digitalization and artificial intelligence upskilling to accelerate the

transition from individual adoption to enterprise-wide impact.

Our key priority is to continue evolving PMI’s culture to fully support

our mission and the evolving requirements of a modern, highly

skilled workforce, while strengthening succession depth to ensure

leadership continuity, organizational resilience, and long-term

sustainable performance.

Sustainable Business Value

At PMI, the long-term sustainability of our business is not an outcome

of our strategy. It is the strategy itself. It informs how we secure

critical resources, manage risks, meet stakeholders’ expectations,

and future proof a business built to deliver results today while

securing the ability to deliver tomorrow.

Our approach to value creation extends beyond financial

performance to encompass the full range of resources and

relationships on which our long-term success depends. We recognize

that sustainable business results require investing deliberately in

multiple forms of capital: human, intellectual, natural, manufactured,

and social, alongside financial capital. By proactively addressing

environmental and social impacts in our products and operations, we

strengthen our ability to manage risks, capitalize on opportunities,

and build resilience in a dynamic operating environment.

For further information on how PMI creates, preserves, and enhances

value over the short, medium, and long term, we invite you to read

our 2025 Value Report, which we plan to publish in the coming weeks.

Board of Directors

In February 2026, Dessislava Temperley informed the Board that

she would not stand for re-election this year. On behalf of the

entire organization, we sincerely thank Dessislava, who joined the

Board in 2021, for her valued contributions to the company as a

Director and member of the Audit and Risk Committee, and as a

former member of the Consumer Relationships and Regulation, and

Finance Committees.

Looking Ahead

The past year was marked by persistent global uncertainty and a

demanding operating backdrop. It also clearly demonstrated the

strength of PMI and the leadership position we have built. Despite

ongoing volatility, our people delivered with focus and conviction,

achieving strong results and reaching important milestones in our

smoke-free journey. These achievements reinforce our confidence

in the long-term potential of our strategic shift away from

combustible tobacco, anchored by our leadership in smoke-free

products, and complemented by growth opportunities in wellness

over the long term.

As outlined in our 2025 full-year results announcement, we are

confident in the company’s next growth phase and are targeting

compound annual growth rates for 2026 - 2028 of: 6% to 8% for net

revenues, on an organic basis, including smoke-free products volume

growth of high single-digit to low-teens driving total shipment

volume growth; 8% to 10% for adjusted operating income on an

organic basis; and 9% to 11% for adjusted diluted EPS, excluding

currency, assuming current corporate income tax rates and no share

repurchases.

We remain committed to science, innovation, responsible marketing,

and transparency as we scale our smoke‑free portfolio and broaden

our impact. PMI’s ambition remains clear: to replace cigarettes with

smoke‑free products and to deliver sustainable, long‑term value

to our shareholders while contributing to improved public‑health

outcomes globally.

Jacek Olczak,

Group CEO PMI

March 10, 2026

André Calantzopoulos,

Chairman of the Board

Xavier analysis
The CEO and Chairman express strong confidence in the company's performance, strategic direction towards smoke-free products, and future growth prospects, celebrating numerous achievements and market leadership positions.
Strategic themes by emphasis
#1Smoke-Free Transformation & Harm Reduction
#2Strong Financial Performance & Shareholder Value
#3Organizational Evolution & Digital Transformation
#4Combustible Business Management
#5Sustainability & Holistic Value Creation
#6Regulatory Advocacy for Smoke-Free Products
9 named projects & initiatives
IQOS, VEEV, ZYN, ILUMA i, BONDS, Marlboro +3 more
6 product, 2 restructuring, 1 other
Forward-looking statements
5 total: 2 quantified, 1 directional, 2 vague
Capital allocation priority
Organic Growth (Smoke-Free Products) → Dividends → Investment in Human, Intellectual, Natural, Manufactured, and Social Capital → Share Repurchases (explicitly excluded from 2026-2028 targets)
Key quotes
“2025 was another remarkable year for PMI, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and further ”
Summarizes the company's strong financial and volume performance, highlighting the increasing contribution of the smoke-free segment.
“Our business yet again delivered best-in-class top- and bottom-line growth and outperformed the industry.”
Emphasizes the company's strong competitive position and market leadership relative to peers.
View 2025 Annual Report (PDF) →3 letters on file (2025, 2024, 2022) · Full history with Pro
Executive compensation
Signal
NameTitleTotal compensation
Jacek OlczakGroup CEO PMI$29,072,171
Emmanuel BabeauGroup Chief Financial Officer$26,893,983
Massimo AndolinaPresident, Europe Region$7,882,782
Frederic de WildeCEO PMI International$10,788,010
Stacey KennedyCEO PMI U.S.$6,621,252
Source: DEF 14A proxy statement · 2026-03-26
Governance
Pro
Dual-class shares: No
Poison pill: No
Clawback policy: Yes
Stock ownership req.: Yes
Shareholder proposals
Report on filter cleanup costs and extended producer responsibility laws for fil
AGAINST
Pending
Debt intelligence
Pro
23 debt instruments · 10 unique covenants
-5.33x
Debt / Equity
2.5x
Net Debt / EBITDA
$44.1B
Net debt
72%
Debt / Assets
Credit facilities & debt instruments
Revolver
Revolving Credit Facility
Matures 2029-01-29 · Filed 2025-12-11
Revolver $2,000,000,000
US$2,000,000,000 REVOLVING CREDIT FACILITY (including a US$800,000,000 swingline option)
Matures 2031-01-29 · Filed 2025-12-11
Floating · SOFR | EURIBOR | Fed Funds | Prime
unsecured
Revolver €1,500,000,000
€ 1,500,000,000 REVOLVING CREDIT FACILITY
Matures 2028-01-29 · Filed 2024-12-17
Floating · EURIBOR
unsecured
Term Loan
Amendment No. 2 to Term Loan Credit Agreement
Matures · Filed 2024-02-08
Revolver
Revolving Credit Facility
Matures 2025-01-28 · Filed 2024-01-24
Revolver $2,500,000,000
Credit Agreement relating to a Revolving Credit Facility
Matures 2028-09-29 · Filed 2023-09-20
Floating · SOFR
17 additional agreements on file
Financial covenants
Maximum Liens Securing Debt
≤ 15%
Liens securing Debt / Consolidated Tangible Assets
US$2,000,000,000 REVOLVING CREDIT FACILITY (includ
Limitation on Liens
not in excess of 15% of Consolidated Tangible Assets
Debt secured by Liens
€ 1,500,000,000 REVOLVING CREDIT FACILITY
Limitation on Liens
≤ 15% of Consolidated Tangible Assets
Debt secured by Liens
US$2,500,000,000 REVOLVING CREDIT FACILITY (includ
Limitation on Liens
≤ 15%
Debt secured by Liens / Consolidated Tangible Assets
364-DAY BRIDGE CREDIT AGREEMENT
Limitation on Liens (General Basket)
≤ 15% of Consolidated Tangible Assets
Debt secured by Liens
US$2,000,000,000 REVOLVING CREDIT FACILITY (includ
Limitation on Liens (Existing Credit Agreement Debt)
≤ $400,000,000
Debt secured by Liens under Section 5.2(a)(iii)
US$2,000,000,000 REVOLVING CREDIT FACILITY (includ
Limitation on Liens (Industrial Revenue Bonds)
≤ $200,000,000
Debt secured by Liens under Section 5.2(a)(iv)
US$2,000,000,000 REVOLVING CREDIT FACILITY (includ
ERISA Liability Event of Default
> $500,000,000
Aggregate liability from ERISA Events, Multiemployer Plan withdrawal/termination
US$2,000,000,000 REVOLVING CREDIT FACILITY (includ
2 additional covenants on file
Cross-default risk
10 agreements contain cross-default provisions — a covenant breach on one facility may trigger default on others.
Xavier risk radar
Pro
Covenant headroom
No financial covenants on file
Earnings quality
High quality (cash conversion 1.1x)
Risk trend
Risk increasing — PMI may be unsuccessful in its efforts to introduce, commercialize, and grow smo
Mgmt narrative
Management tone: Cautiously optimistic
Analyst drift
Consensus Buy — targets stable
Insider sentiment
Pattern detection — 90 days needed
Signal history
Signal
DateDirectionConf.Agree.ThesisPriceType
Jul 12, 2026 NEUTRAL 6.2/10 100% PM trades at ~25.6x TTM P/E and ~22x forward P/E at $181.62, sitting 6% below its 52-week high with ... $181.62 Sched.
Jul 11, 2026 NEUTRAL 6.0/10 100% PM is a high-quality defensive name, but at ~25.6x trailing earnings with essentially flat revenue g... $181.62 Sched.
Jun 07, 2026 NEUTRAL 6.0/10 100% PM has rallied ~1.9% on the day but remains ~7.6% below its 52-week high and sits above analyst cons... $178.29 Sched.
May 31, 2026 NEUTRAL 6.3/10 75% PM trades at ~25x TTM P/E with near-zero revenue growth and negative reported earnings growth, leavi... $177.38 Sched.
May 24, 2026 NEUTRAL 5.3/10 100% PM is trading within 2.2% of its 52-week high at $188.99 with a consensus price target of ~$192.79, ... $188.99 Sched.
May 17, 2026 NEUTRAL 6.2/10 100% PM is trading within 2% of its 52-week high at $189.61 after a sharp post-earnings rally fueled by Q... $189.61 Sched.
May 10, 2026 NEUTRAL 6.4/10 75% PM is trading at ~$171, roughly 11% below its 52-week high and ~10.5% below the analyst consensus ta... $170.99 Sched.
May 03, 2026 NEUTRAL 6.5/10 75% PM has delivered genuinely exceptional fundamental performance — adjusted EPS +14.8% in FY2025 and s... $166.38 Sched.
Apr 24, 2026 NEUTRAL 6.8/10 75% PM delivered a genuine Q1 2026 earnings beat — adjusted EPS of $1.96 vs. $1.83 estimate (+7.1%) and ... $169.19 Event
Apr 12, 2026 NEUTRAL 6.6/10 50% PM is trading roughly 16% below its 52-week high, weighed down by FDA scrutiny of ZYN Ultra, Japan t... $160.45 Sched.
Showing last 10 signals
PM Philip Morris International Inc.
Signal
FY2026 annual report (10-K filed 2026-02-06)
INCOME STATEMENT
? Revenue
$40,648 million 7.3% YoY
? Operating income
$14,892 million
? Net income
$11,348 million
? Free cash flow
$10,664 million
? EPS (diluted)
$1.56
? Dividend per share
$5.88
Click any row to expand the plain-English explanation. Source: SEC EDGAR XBRL filings.
Capital intelligence
Signal
Weighted Average Cost of Capital · Return on Invested Capital · Economic Value Added
ROIC
29.79%
WACC
5.55%
🟢 VALUE CREATOR — EVA Spread: 24.24%
? WACC
5.55%
? Cost of equity
6.48%
? Cost of debt (after-tax)
0.32%
? Capital structure
E: 84.89% / D: 15.11%
? ROIC
29.79%
? EVA
$8.3B
? NOPAT
$10.1B
Risk-free rate: 4.25% (10Y Treasury) · Equity risk premium: 5.50% · Sources: total_debt: Gemini 10-K, operating_income: XBRL TTM (4Q sum), interest_expense: Derived (OI - PTI), invested_capital: Equity + Debt - Cash
Xavier consensus signals are intelligence outputs, not investment advice. All signals are generated by a multi-model AI system and reflect public information at time of generation. Past signal accuracy does not guarantee future performance. Wall Street analyst consensus sourced from public disclosures, summarized weekly. Financial data sourced from SEC EDGAR and yfinance. Insider transactions sourced from SEC EDGAR Form 4 filings. Updated Jul 12, 2026.